During CRC development, HIF-1α binds to the SOX12 (SRY-box transcription factor 12) promoter to increase SOX12 expression, which further increases the SOX12-mediated expression of GLS and GOT2, leading to cellular metabolism adaptation that promotes tumor progression [93]. Here, SOX12 is linked to neoplasm.